BALAXI PHARMACEUTICALS LIMITED Total Liabilities
BALAXI PHARMACEUTICALS LIMITED total liabilities. Based on the latest financial reports, BALAXI PHARMACEUTICALS LIMITED (BALAXI) has total liabilities worth Rs879.53 Million INR (≈ $9.51 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check BALAXI PHARMACEUTICALS LIMITED liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of BALAXI PHARMACEUTICALS LIMITED (2013–2026)
Total liabilities of BALAXI PHARMACEUTICALS LIMITED from 2013 to 2026. This chart illustrates how BALAXI PHARMACEUTICALS LIMITED's total liabilities have evolved over time, based on quarterly financial data. Explore BALAXI PHARMACEUTICALS LIMITED (BALAXI) investment intensity to see how much of total assets are deployed in long-term investments.
BALAXI PHARMACEUTICALS LIMITED Competitors by Total Liabilities
The table below lists competitors of BALAXI PHARMACEUTICALS LIMITED ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Rayong Wire Industries Public Company Limited
BK:RWI
|
Thailand | ฿169.31 Million |
|
Observe Medical Asa
OL:OBSRV
|
Norway | Nkr71.21 Million |
|
Prg Holdings Bhd
KLSE:7168
|
Malaysia | RM298.83 Million |
|
Prochem S.A.
WAR:PRM
|
Poland | zł99.03 Million |
|
GreenPro Capital Corp
NASDAQ:GRNQ
|
USA | $2.58 Million |
|
Rougier S.A.
PA:ALRGR
|
France | €65.90 Million |
|
Raspberry Pi Holdings PLC
LSE:RPI
|
UK | GBX67.51 Million |
|
Volex Plc
LSE:VLX
|
UK | GBX586.67 Million |
Liability Composition Analysis (2013–2026)
This chart breaks down BALAXI PHARMACEUTICALS LIMITED's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of BALAXI PHARMACEUTICALS LIMITED.
Liquidity & Leverage Metrics
BALAXI PHARMACEUTICALS LIMITED Total Liabilities Ratios Explained
BALAXI PHARMACEUTICALS LIMITED total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.51 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BALAXI PHARMACEUTICALS LIMITED's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BALAXI PHARMACEUTICALS LIMITED (2013–2026)
The table below shows the annual total liabilities of BALAXI PHARMACEUTICALS LIMITED from 2013 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs879.53 Million ≈ $9.51 Million |
+11.89% |
| 2025-03-31 | Rs786.06 Million ≈ $8.50 Million |
+37.96% |
| 2024-03-31 | Rs569.79 Million ≈ $6.16 Million |
+0.33% |
| 2023-03-31 | Rs567.89 Million ≈ $6.14 Million |
-10.29% |
| 2022-03-31 | Rs633.07 Million ≈ $6.85 Million |
+82.44% |
| 2021-03-31 | Rs347.00 Million ≈ $3.75 Million |
+321.88% |
| 2020-03-31 | Rs82.25 Million ≈ $889.51K |
+217.90% |
| 2019-03-31 | Rs25.87 Million ≈ $279.81K |
+1859.33% |
| 2018-03-31 | Rs1.32 Million ≈ $14.28K |
-39.26% |
| 2017-03-31 | Rs2.17 Million ≈ $23.51K |
+5061.73% |
| 2016-03-31 | Rs42.12K ≈ $455.50 |
-7.73% |
| 2015-03-31 | Rs45.65K ≈ $493.67 |
-98.92% |
| 2014-03-31 | Rs4.24 Million ≈ $45.88K |
-12.73% |
| 2013-03-31 | Rs4.86 Million ≈ $52.57K |
-- |
About BALAXI PHARMACEUTICALS LIMITED
Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in India, Africa, and Latin America. The company offers pharmaceutical products across various therapeutic areas, including antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpaste. The company was formerly known as Balaxi Ve… Read more